Management of chemotherapy-induced anemia in patients with lung cancer (LC): A comparative study of erythropoietic agents

被引:0
|
作者
Tiotiu, Angelica [1 ]
Clement-Duchene, Christelle [1 ]
Vaillant, Pierre [1 ]
Barbier, Pauline [2 ]
Tiotiu, Decebal [3 ]
Martinet, Yves [1 ]
机构
[1] CHU Brabois, Pulm Dis, F-54000 Nancy, France
[2] CHU Brabois, Pharm, F-54000 Nancy, France
[3] CHU Brabois, Publ Hlth, F-54000 Nancy, France
关键词
Lung cancer / Oncology; Palliative care; Treatments;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
4158
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Management of chemotherapy-induced anemia in lung cancer
    Tiotiu, A.
    Clement-Duchene, C.
    Martinet, Y.
    REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (08) : 809 - 821
  • [2] Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC)
    Tiotiu, Angelica
    Clerc-Urmes, Isabelle
    Martinet, Yves
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [3] Medical cost considerations of fixed dosing regimens of erythropoietic agents in patients with chemotherapy-induced anemia
    Lefebvre, P.
    Vekeman, F.
    Duh, M.
    Watson, S.
    Mckenzie, R. S.
    VALUE IN HEALTH, 2007, 10 (03) : A128 - A128
  • [4] CHEMOTHERAPY-INDUCED ANEMIA IN PATIENTS WITH PRIMARY LUNG-CANCER
    OKAMOTO, H
    SAIJO, N
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    TAMURA, T
    OHE, Y
    KOJIMA, A
    KUNIKANE, H
    KARATO, A
    OHMATSU, H
    YAMAKIDO, M
    ANNALS OF ONCOLOGY, 1992, 3 (10) : 819 - 824
  • [5] Extended-dosage-interval regimens of erythropoietic agents in chemotherapy-induced anemia
    Muller, Raymond J.
    Baribeault, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (24) : 2547 - 2556
  • [6] Dose conversion of erythropoietic agents in chemotherapy-induced anemia: A meta-analysis
    Rosberg, J
    Oster, EF
    Wu, EQ
    Fastenau, J
    Piech, CT
    VALUE IN HEALTH, 2003, 6 (03) : 229 - 230
  • [7] Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs)
    Burton, Tanya
    Hoaglin, David
    Larholt, Kay
    Apgar, Elizabeth
    Pashos, Chris
    Bookhart, Brahim
    Corral, Mitra
    Piech, Catherine Tak
    McKenzie, R. Scott
    BLOOD, 2008, 112 (11) : 472 - 472
  • [8] The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents
    Mhaskar, Rahul
    Wao, Hesborn
    Miladinovic, Branko
    Kumar, Ambuj
    Djulbegovic, Benjamin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [9] Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia
    Pashos, Chris L.
    Larholt, Kay
    Fraser, Kimberly A.
    McKenzie, R. Scott
    Senbetta, Mekre
    Piech, Catherine Tak
    SUPPORTIVE CARE IN CANCER, 2012, 20 (01) : 159 - 165
  • [10] Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia
    Chris L. Pashos
    Kay Larholt
    Kimberly A. Fraser
    R. Scott McKenzie
    Mekré Senbetta
    Catherine Tak Piech
    Supportive Care in Cancer, 2012, 20 : 159 - 165